ReviR Therapeutics leverages AI algorithms and genetic technology to develop RNA-targeting medicines which creates possible cures for tumors, infections and rare diseases.
Revir
Close
AsiaAI/Computing-Driven TherapeuticsArtificial IntelligenceBiotechnology
Yang Li
Founder and Chairman
Favorite Innovator
Aristotle